Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
Site Search
Showing 1 - 2 of 2 results
News
|
|
2 min read
The additional funding will support a Phase 2 clinical trial for an inhaled antisense oligonucleotide drug for people with cystic fibrosis who have the splicing mutation 3849+10Kb C-to-T.
Press Release
|
|
3 min read